These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21425557)

  • 21. Helicobacter pylori eradication and histopathological esophagitis in dyspeptic patients.
    Amini M; Karbasi A; Khedmat H; Jeihounian M
    Trop Gastroenterol; 2010; 31(3):175-9. PubMed ID: 21560521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
    Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
    Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of Helicobacter pylori eradication on appearance of gastro-oesophageal reflux disease].
    Popović D; Stanković-Popović V; Milosavljević T; Jovanović I; Pesko P; Simić A; Micev M; Milicić B; Kristić M
    Acta Chir Iugosl; 2006; 53(3):41-8. PubMed ID: 17338199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carditis: a relevant marker of gastroesophageal reflux disease. Data from a prospective central European multicenter study on histological and endoscopic diagnosis of esophagitis (histoGERD trial).
    Pinto D; Plieschnegger W; Schneider NI; Geppert M; Bordel H; Höss GM; Eherer A; Wolf EM; Vieth M; Langner C
    Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 30137321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
    Fallone CA; Barkun AN; Friedman G; Mayrand S; Loo V; Beech R; Best L; Joseph L
    Am J Gastroenterol; 2000 Apr; 95(4):914-20. PubMed ID: 10763937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Carditis': an objective histological marker for pathologic gastroesophageal reflux disease.
    Csendes A; Smok G; Burdiles P; Sagastume H; Rojas J; Puente G; Quezada F; Korn O
    Dis Esophagus; 1998 Apr; 11(2):101-5. PubMed ID: 9779365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection.
    Wu JC; Chan FK; Ching JY; Leung WK; Lee YT; Sung JJ
    Gastrointest Endosc; 2002 Apr; 55(4):461-5. PubMed ID: 11923754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does a relationship still exist between gastroesophageal reflux and Helicobacter pylori in patients with reflux symptoms?
    Grande M; Lisi G; De Sanctis F; Grande S; Esser A; Campanelli M; Balassone V; Milito G; Villa M
    World J Surg Oncol; 2014 Dec; 12():375. PubMed ID: 25479911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and morphological aspects of Helicobacter pylori invasion in reflux esophagitis].
    Galimov OV; Fedorov SV; Nurtdinov MA; Abdullina GA; Shumkin AM; Khanov VO
    Klin Khir; 1997; (1):17-8. PubMed ID: 9254257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Helicobacter pylori gastric infection is a protection factor for gastroesophageal reflux disease].
    Nogueira-de Rojas JR; Jiménez-González A; Cervantes-Solís C
    Rev Gastroenterol Mex; 2002; 67(1):22-7. PubMed ID: 12066427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathology of gastric cardia: a prospective, endoscopic, and morphologic study.
    Cestari R; Villanacci V; Bassotti G; Rossi E; Casa DD; Missale G; Minelli L; Cengia P; Gambarotti M; Pirali F; Donato F; Genta RM
    Am J Surg Pathol; 2007 May; 31(5):706-10. PubMed ID: 17460453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan.
    Sugimoto M; Uotani T; Ichikawa H; Andoh A; Furuta T
    Digestion; 2016; 93(1):24-31. PubMed ID: 26789391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Helicobacter pylori eradication on reflux esophagitis in Japanese patients.
    Yagi S; Okada H; Takenaka R; Miyoshi M; Suzuki S; Toyokawa T; Kawahara Y; Yamamoto K
    Dis Esophagus; 2009; 22(4):361-7. PubMed ID: 19191852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of dilated intercellular space and histopathologic scores in gastroesophageal reflux disease.
    Cui R; Zhang H; Zhou L; Lu J; Xue Y; Wang Y; Yan X; Lin L; Lin S
    Dis Esophagus; 2015; 28(6):530-7. PubMed ID: 25130660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology?
    Salvatore S; Hauser B; Vandemaele K; Novario R; Vandenplas Y
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):210-5. PubMed ID: 15699699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic evaluation of gastro-esophageal reflux disease.
    Armstrong D
    Yale J Biol Med; 1999; 72(2-3):93-100. PubMed ID: 10780570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination.
    Du J; Liu J; Zhang H; Yu CH; Li YM
    World J Gastroenterol; 2007 Dec; 13(45):6009-15. PubMed ID: 18023091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-definition endoscopy with i-Scan and Lugol's solution for more precise detection of mucosal breaks in patients with reflux symptoms.
    Hoffman A; Basting N; Goetz M; Tresch A; Mudter J; Biesterfeld S; Galle PR; Neurath MF; Kiesslich R
    Endoscopy; 2009 Feb; 41(2):107-12. PubMed ID: 19214887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.